Element Capital Management LLC Iovance Biotherapeutics, Inc. Transaction History

Element Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 13, 2019	SELL	$8.41 - $11.26 $1.94 Million - $2.6 Million	-230,625 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$7.51 - $11.93 $1.51 Million - $2.41 Million	201,697 Added 697.24%	230,625 $2.04 Million
Q3 2018 Nov 14, 2018	BUY	$11.25 - $17.7 $118,057 - $185,743	10,494 Added 56.93%	28,928 $325,000
Q2 2018 Aug 14, 2018	BUY	$12.45 - $16.95 $229,503 - $312,456	18,434 New	18,434 $236,000

314

241M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.35B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Element Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Element Capital Management LLC with notifications on news.